Gary Magnant is a General Partner at Formation Venture Engineering Fund II and holds C-suite roles at Triple Sharp Venture Engineering, LLC, TriBiotica, and NonExomics. He co-founded and formerly served as CEO of Thrive Bioscience, Inc., Sage Science, Inc., and Owl Scientific, now part of Thermo Fisher.
Ruchi Chauhan did her Ph.D. working at the Harvard University. Thereafter, she worked as a scientist at Merck Pharmaceuticals, Compass Therapeutics, and at the University of Cambridge. She has 20 years of research experience working in proteogenomics, molecular target validation, drug discovery, cancer, and neurodegenerative disorders. She was the head of the Gene Therapy vector...
Sudhakaran Prabakaran is a computational biologist with extensive expertise in machine learning approaches. He did his Ph.D. at the University of Cambridge on schizophrenia and bipolar disorder. His research involved generating and integrating large scale omics datasets using machine learning methodologies to identify schizophrenia and bipolar disease signatures. After his Ph.D. he moved to Harvard...
